Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...

Upadacitinib 15 mg — but not 7.5 mg — alongside a glucocorticoid taper demonstrated superior efficacy to placebo with a ...

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant ...

Novartis NVS announced that a late-stage study of its interleukin-17A inhibitor, Cosentyx (secukinumab), has failed to meet ...

How to pick the best cell phone plans for seniors (Image credit: 10'000 Hours) When researching the best cell phone plans for seniors, I've learned that there are a few factors to consider.

The pharmacist at this giant eagle will consistently put off filling a prescription until the next employee comes in. You can call 4 times to ask and make sure it is ready, it does not matter.

Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children undergoing HSCT.

Learn all about this new play, inspired by a fascinating true story, and plan your Giant London theatre trip Rosenblatt’s play is set in 1983. He imagines an emergency meeting between Dahl, his ...

Looking to switch phone plan providers? These are our top postpaid and prepaid plans from AT&T, T-Mobile, Verizon, Mint Mobile, US Mobile and more.

Novartis Drug Cosentyx Fails Late-stage Trial for Artery Disease Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), a ...

Searching for a new wireless provider with 5G service options? Find out more about Verizon Wireless’s plans from ConsumerAffairs.